HeartHab, Can a Patient-tailored Application Support Coronary Artery Disease Patients During Rehabilitation?

Not Applicable

Completed

• Conditions: Coronary Artery Disease
• Interventions: Behavioral: HeartHab application intervention

• Registration Number: NCT02668757
• Lead Sponsor: Hasselt University

Brief Summary

The HeartHab study is a pilot trial in which coronary artery disease patients (n = 15-30) are given the HeartHab application. The HeartHab application is a smarthphone based mobile application that serves as a secondary prevention tool, to support cardiac patients after their phase II cardiac rehabilitation program. During study period (4-6 weeks), participating patients will be asked to use the application. HeartHab includes a module devoted to therapy compliance, one to exercise training prescription and one to risk factor control. HeartHab aims to motivate the patient to improve his/her self-management skills and hence decrease cardiovascular morbidity (and mortality).

Motivational aspects and usability data will be collected during study period by means of app logs and/or questionnaires/interviews.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-01-27
• Study First Submitted QC: 2016-01-27
• Study First Posted: 2016-01-29
• Study Start: 2016-03
• Primary Completion: 2017-12-31
• Study Completion: 2017-12-31
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-26
• Last Update Posted: 2018-02-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patients with coronary artery disease for which they received a percutaneous coronary intervention, coronary artery bypass grafting or drugs only.
• Patients that have completed the standard cardiac rehabilitation program
• Patients who have access to a computer and a WiFi internet connection
• Patients that are able to go to the rehabilitation centre ReGo of Jessa Hospital
• Patients who signed the informed consent document

Exclusion Criteria

• Patients with a history of VF, sustained VT and/or supraventricular tachycardia during the last 6 months before enrollment.
• Patients who due to cognitive, neurological and/or musculoskeletal constraints are unable to ride a bicycle.
• Patients with a pacemaker or defibrillator.
• Non-Dutch speaking patients
• Patients who simultaneously participate in another study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
HeartHab application arm	HeartHab application intervention	Patients in the HeartHab application arm will receive the mobile application during study period.

Primary Outcome Measures

Name	Time	Method
Impact on motivation	week 6	By means of a questionnaire and an interview, questions are asked about participants' motivation for a tour

Secondary Outcome Measures

Name	Time	Method
Usability of the HeartHab application	week 6	By means of a questionnaire and an interview, the participants are asked about the usability of the application. This information will give insights in parts of the application that could be improved considering the usability

Trial Locations

Locations (1)

Jessa Ziekenhuis; 🇧🇪 Hasselt, Belgium